BASF to Develop a High Purity Poloxamer for Mast Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. ERAS
2. TREX
3. SPRO
4. ORCL
5. IBM
6. SPY
7. HCLT:IN
8. KKR
9. JPM
10. AAPL

Go back to BASF to Develop a High Purity Poloxamer for Mast Therapeutics
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.14 --0 (-0%)
Previous Close $8.14    52 Week High $0.71 
Open $8.14    52 Week Low $0.07 
Day High $8.14    P/E N/A 
Day Low $8.14    EPS $-0.35 
Volume 263,181       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.14 --0 (-0%)
Previous Close $8.14    52 Week High $0.71 
Open $8.14    52 Week Low $0.07 
Day High $8.14    P/E N/A 
Day Low $8.14    EPS $-0.35 
Volume 263,181